UPSHER-SMITH 150 mg Pill - yellow & gray capsule/oblong, 11mm
Generic Name: topiramate
Pill with imprint UPSHER-SMITH 150 mg is Yellow & Gray, Capsule/Oblong and has been identified as Qudexy XR 150 mg. It is supplied by Upsher-Smith Laboratories, Inc.
Qudexy XR is used in the treatment of Migraine Prevention; Lennox-Gastaut Syndrome; Seizure Prevention; Epilepsy; Seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Qudexy XR 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for UPSHER-SMITH 150 mg

Qudexy XR
- Generic Name
- topiramate
- Imprint
- UPSHER-SMITH 150 mg
- Strength
- 150 mg
- Color
- Yellow & Gray
- Size
- 11.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Upsher-Smith Laboratories, Inc.
- Inactive Ingredients
-
microcrystalline cellulose,
hypromellose 2910 (6 mPa.s),
diethyl phthalate,
titanium dioxide,
ferrosoferric oxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00245-1075 | Upsher-Smith Laboratories Inc. |
00832-1075 | Upsher-Smith Laboratories Inc. |
Related images for "UPSHER-SMITH 150 mg"
More about Qudexy XR (topiramate)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Topamax, Trokendi XR, Eprontia, Topiragen
Professional resources
Other brands
Topamax, Trokendi XR, Eprontia
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.